Equity

SHSSX

Health Sciences Opportunities Fund

Overview

Loading

Performance

Performance

Growth of Hypothetical $10,000

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart
  1y 3y 5y 10y
27.34 15.25 14.01 17.25
Benchmark (%) 24.60 12.42 12.61 16.07
Morningstar Category Avg. (%) 23.51 11.82 9.42 14.88
Morningstar Ranking 86/141 16/122 16/114 26/93
Morningstar Quartile 2 1 1 2
Lipper Category Avg. (%) 32.36 11.25 10.97 15.88
Lipper Ranking 62/108 15/92 14/83 20/64
Lipper Quartile 3 1 1 2
  YTD 1m 3m 1y 3y 5y 10y
10.73 -0.81 6.42 27.34 53.07 92.62 391.23
Benchmark (%) 8.41 -1.28 6.48 24.60 42.07 81.11 343.93
Morningstar Category Avg. (%) 9.68 -1.54 0.95 23.51 39.80 56.82 300.26
Lipper Category Avg. (%) 11.34 0.54 5.13 32.36 38.49 70.94 345.79
  2015 2016 2017 2018 2019
Total Return (%) 11.31 -5.79 25.15 8.27 25.64
Benchmark (%) 7.14 -3.33 23.13 5.63 22.11
Morningstar Category Avg. (%) 8.05 -10.60 24.31 -0.40 26.23
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. Effective as of May 31, 2018, the performance information for periods prior to the inception date of the share class shows the performance of the Fund’s Investor A Shares. The performance of this share class would be substantially similar to Investor A Shares because this share class and Investor A Shares invest in the same portfolio of securities and performance would only differ to the extent that this share class and Investor A Shares have different expenses. For performance periods prior to May 31, 2018, the performance information for periods prior to the inception date of the share class shows the performance of the Fund’s Investor A Shares, adjusted to reflect the fees and expenses applicable to such share class. See the fund prospectus for more details.

Key Facts

Key Facts

Size of Class (Millions) as of Dec 03, 2020 $5,453.4 M
Size of Fund (Millions) as of Dec 03, 2020 $10,170.7 M
Share Class launch date Oct 16, 2000
Asset Class Equity
Morningstar Category Health
Lipper Classification Health/Biotech Funds
Benchmark Index Russell 3000 HealthCare Index
CUSIP 091937540
Distribution Frequency Annual
Number of Holdings as of Oct 30, 2020 132
Max Offer Price as of Dec 03, 2020 $78.26
Open to New Investors Yes
Turnover Percent in the Annual Report as of Jun 30, 2020 41%

Portfolio Characteristics

Portfolio Characteristics

P/B Ratio as of Oct 30, 2020 4.71
P/E Ratio - Forward as of Oct 30, 2020 20.18
Average Market Cap (Millions) as of Oct 30, 2020 $ 102,923.6 M
Alpha (3y) as of Nov 30, 2020 0.21
R-Squared (3y) as of Nov 30, 2020 97.35
Beta (3y) as of Nov 30, 2020 0.95
Best 3-Month Return Over the Last 3 Years 3 months ending Jun 30, 2020 17.54%
Worst 3-Month Return Over the Last 3 Years 3 months ending Mar 31, 2020 -11.49%
Fund Standard Deviation (3y) as of Nov 30, 2020 15.88
Active Share as of Oct 30, 2020 39.91%

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Sustainability Characteristics

Sustainability Characteristics

Sustainability Characteristics can help investors integrate non-financial, sustainability considerations into their investment process. These metrics enable investors to evaluate funds based on their environmental, social, and governance (ESG) risks and opportunities. This analysis can provide insight into the effective management and long-term financial prospects of a fund.


The metrics below have been provided for transparency and informational purposes only. The existence of an ESG rating is not indicative of how or whether ESG factors will be integrated into a fund. The metrics are based on MSCI ESG Fund Ratings and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. For more information regarding a fund's investment strategy, please see the fund's prospectus.


Review the MSCI methodology behind Sustainability Characteristics, using links below.

MSCI ESG Fund Rating (AAA-CCC) as of Nov 01, 2020 A
MSCI ESG Quality Score (0-10) as of Nov 01, 2020 7.0
MSCI ESG Quality Score - Peer Percentile as of Nov 01, 2020 76.85%
MSCI ESG % Coverage as of Nov 01, 2020 97.73%
Fund Lipper Global Classification as of Nov 01, 2020 Equity Sector Healthcare
MSCI Weighted Average Carbon Intensity (Tons CO2E/$M SALES) as of Nov 01, 2020 20.51
Funds in Peer Group as of Nov 01, 2020 324
All data is from MSCI ESG Fund Ratings as of Nov 01, 2020, based on holdings as of Jun 30, 2020. As such, the fund’s sustainable characteristics may differ from MSCI ESG Fund Ratings from time to time.

To be included in MSCI ESG Fund Ratings, 65% of the fund’s gross weight must come from securities covered by MSCI ESG Research (certain cash positions and other asset types deemed not relevant for ESG analysis by MSCI are removed prior to calculating a fund’s gross weight; the absolute values of short positions are included but treated as uncovered), the fund’s holdings date must be less than one year old, and the fund must have at least ten securities. For newly launched funds, sustainability characteristics are typically available 6 months after launch.

Business Involvement

Business Involvement

Business Involvement metrics can help investors gain a more comprehensive view of specific activities in which a fund may be exposed through its investments.


Business Involvement metrics are not indicative of a fund’s investment objective, and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. For more information regarding a fund's investment strategy, please see the fund's prospectus.


Review the MSCI methodology behind the Business Involvement metrics, using links below.

MSCI - Controversial Weapons as of Oct 30, 2020 0.00%
MSCI - UN Global Compact Violators as of Oct 30, 2020 0.00%
MSCI - Nuclear Weapons as of Oct 30, 2020 0.00%
MSCI - Thermal Coal as of Oct 30, 2020 0.00%
MSCI - Civilian Firearms as of Oct 30, 2020 0.00%
MSCI - Oil Sands as of Oct 30, 2020 0.00%
MSCI - Tobacco as of Oct 30, 2020 0.00%

Business Involvement Coverage as of Oct 30, 2020 95.13%
Percentage of Fund not covered as of Oct 30, 2020 4.87%
BlackRock business involvement exposures as shown above for Thermal Coal and Oil Sands are calculated and reported for companies that generate more than 5% of revenue from thermal coal or oil sands as defined by MSCI ESG Research. For the exposure to companies that generate any revenue from thermal coal or oil sands (at a 0% revenue threshold), as defined by MSCI ESG Research, it is as follows: Thermal Coal 0.00% and for Oil Sands 0.00%.

Business Involvement metrics are calculated by BlackRock using data from MSCI ESG Research which provides a profile of each company’s specific business involvement. BlackRock leverages this data to provide a summed up view across holdings and translates it to a fund's market value exposure to the listed Business Involvement areas above.


Business Involvement metrics are designed only to identify companies where MSCI has conducted research and identified as having involvement in the covered activity. As a result, it is possible there is additional involvement in these covered activities where MSCI does not have coverage. This information should not be used to produce comprehensive lists of companies without involvement. Business Involvement metrics are only displayed if at least 1% of the fund’s gross weight includes securities covered by MSCI ESG Research.

Fees

Fees

as of current prospectus
Gross Expense Ratio 0.86%
Net Expense Ratio 0.86%

Net Expense Ratio excluding Investment Related Expenses is 0.85%

  • Acquired Fund Fees and Expenses 0.01%
  • Interest expense 0.00%

Ratings

Ratings

Morningstar Rating

4
Overall Morningstar Rating for Health Sciences Opportunities Fund, Class Inst, as of Nov 30, 2020 rated against 133 Health Funds based on risk adjusted total return.

Lipper Leader

 
 
 
 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of Oct 31, 2020 out of 92, 12,117, 92, 49 and 92 Funds, respectively in Lipper's Health/Biotech Funds classification.

Holdings

Holdings

as of Oct 30, 2020
Name Weight (%)
UNITEDHEALTH GROUP INC 7.00
ABBOTT LABORATORIES 5.26
JOHNSON & JOHNSON 4.30
THERMO FISHER SCIENTIFIC INC 3.73
MEDTRONIC PLC 2.75
Name Weight (%)
BOSTON SCIENTIFIC CORPORATION 2.64
HUMANA INC 2.55
AMGEN INC 2.51
STRYKER CORPORATION 2.47
ELI LILLY AND COMPANY 2.42

Exposure Breakdowns

Exposure Breakdowns

as of Oct 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Oct 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Oct 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Oct 30, 2020

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team
Xiang Liu
BlackRock Health Sciences Team
Jeffrey Lee
BlackRock Health Sciences Team
Portfolio Manager

Literature

Literature

 

There are many ways to access BlackRock Funds, learn how you can add them to your portfolio